The latest news for pharma industry insiders.

Why it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.

In this video interview with Pharma Commerce Editor Nicholas Saraceno, Jenni Zilka, SVP, community & specialty pharmacy and president, Good Neighbor Pharmacy, clarifies the meaning behind pharmacy deserts, along with reasons for their increase in prominence.

Building strategy, mitigating risk, and achieving success with artificial intelligence.

The latest news for pharma industry insiders.

When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.

New facilities are expected to focus on manufacturing next-generation medicines and biologic medicines.

Various forms of technology—including in the serialization and refrigeration spaces—are necessary in order to keep goods flowing smoothly through the supply chain.

The company—whose foundation has committed $1.5 million for in donations for recovery—is currently working on a plan that will help limit supply disruption.

In the final part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, predicts how the future of data accessibility will unfold.

The latest news for pharma industry insiders.

Alongside the proper temperature-monitoring technology, optimal production control is necessary for success in cold chain drug delivery.

How can buyers maximize the value of their acquisitions?

Are these statistical characteristics—along with social determinants of health—associated with denials of preventive care claims?

In the third part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, details the importance of E2E visibility.

The latest news for pharma industry insiders.

Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.

Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.

As the dust settles on the first round of Medicare negotiations, not everything is what it seems.

Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.

In the second part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, explains the sales and operations planning (SO&P) process that can help create logistical efficiencies.

The latest news for pharma industry insiders.

The session details how these teachings span the entire pharma supply chain.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, discusses obstacles encountered by shippers in the pharmaceutical sector.

The latest news for pharma industry insiders.